Literature DB >> 17336280

Serum cystatin C as a better marker of vancomycin clearance than serum creatinine in elderly patients.

Go Okamoto1, Tatsuichiro Sakamoto, Midori Kimura, Yoshiyuki Ukishima, Akihiro Sonoda, Noriko Mori, Yasuhiro Kato, Toshio Maeda, Yoshiyuki Kagawa.   

Abstract

OBJECTIVES: The purpose of this study is to assess the usefulness of the concentration of cystatin C (Cys-C) in serum for predicting the clearance of vancomycin (CLvcm) compared with the serum concentration of creatinine (SCr) in the elderly.
METHODS: Thirty-nine serum samples were obtained from 24 elderly patients (65 years and older). Creatinine clearance (CLcr) and the glomerular filtration rate calculated from the concentration of Cys-C (GFRcys-c) were estimated using Cockcroft & Gault's formula and Larsson's formula, respectively.
RESULTS: The correlation constant for CLvcm and the reciprocal of Cys-C (p=0.883) was significantly higher than that for CLvcm and the reciprocal of SCr (p=0.575, p<0.005). GFRcys-c was strongly correlated with CLvcm (p=0.883) and the constant was significantly higher than that for the correlation between CLvcm and CLcr (p=0.684, p<0.05). These results suggest that the serum concentration of Cys-C is a more reliable marker for predicting CLvcm than is SCr in elderly patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17336280     DOI: 10.1016/j.clinbiochem.2007.01.008

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  12 in total

1.  Is Cystatin C Good Enough as a Biomarker for Vancomycin Dosing: A Pharmacokinetic Perspective.

Authors:  Guo Yu; Guo-Fu Li
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2020-02       Impact factor: 2.441

Review 2.  Cystatin C as a potential biomarker for dosing of renally excreted drugs.

Authors:  Nguessan Aimé Brou; Evelyne Jacqz-Aigrain; Wei Zhao
Journal:  Br J Clin Pharmacol       Date:  2015-05-28       Impact factor: 4.335

3.  Comparison of the Predictive Performance Between Cystatin C and Serum Creatinine by Vancomycin via a Population Pharmacokinetic Models: A Prospective Study in a Chinese Population.

Authors:  Ren Zhang; Ming Chen; Tao-Tao Liu; Jie-Jiu Lu; Chun-le Lv
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2020-02       Impact factor: 2.441

4.  Population pharmacokinetic analysis of vancomycin using serum cystatin C as a marker of renal function.

Authors:  Akihiro Tanaka; Tetsuya Aiba; Takashi Otsuka; Katsuya Suemaru; Tatsuya Nishimiya; Tomoyoshi Inoue; Mitsuharu Murase; Yuji Kurosaki; Hiroaki Araki
Journal:  Antimicrob Agents Chemother       Date:  2009-11-23       Impact factor: 5.191

5.  Underestimation of the calculated area under the concentration-time curve based on serum creatinine for vancomycin dosing.

Authors:  Sung Joon Jin; Ji Hyun Yoon; Bo Sook Ahn; Ji Ah Chung; Young Goo Song
Journal:  Infect Chemother       Date:  2014-03-21

6.  Usefulness of serum cystatin C to determine the dose of vancomycin in neonate.

Authors:  Jeong Eun Shin; Soon Min Lee; Ho Seon Eun; Min Soo Park; Kook In Park; Ran Namgung
Journal:  Korean J Pediatr       Date:  2015-11-22

7.  Glomerular filtration rate determination by creatinine and cystatin-C in patients with acute pyelonephritis.

Authors:  Hadi Sorkhi; Raheleh Behzadi; Neda Joghtaei; Mohammad Poornasrollah; Ali Bijani
Journal:  Caspian J Intern Med       Date:  2018

8.  Serum cystatin C is a major predictor of vancomycin clearance in a population pharmacokinetic analysis of patients with normal serum creatinine concentrations.

Authors:  Jae-Yong Chung; Sung-Joon Jin; Ji-Hyun Yoon; Young-Goo Song
Journal:  J Korean Med Sci       Date:  2013-01-08       Impact factor: 2.153

Review 9.  Acute kidney injury induced by antimicrobial agents in the elderly: awareness and mitigation strategies.

Authors:  Fumihiro Mizokami; Tomohiro Mizuno
Journal:  Drugs Aging       Date:  2015-01       Impact factor: 4.271

10.  Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: a cohort study.

Authors:  Erin N Frazee; Andrew D Rule; Sandra M Herrmann; Kianoush B Kashani; Nelson Leung; Abinash Virk; Nikolay Voskoboev; John C Lieske
Journal:  Crit Care       Date:  2014-05-29       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.